0001593968-22-000469.txt : 20220215 0001593968-22-000469.hdr.sgml : 20220215 20220215165142 ACCESSION NUMBER: 0001593968-22-000469 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220211 FILED AS OF DATE: 20220215 DATE AS OF CHANGE: 20220215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Halpin Michael CENTRAL INDEX KEY: 0001778858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35280 FILM NUMBER: 22639890 MAIL ADDRESS: STREET 1: C/O VERICEL CORPORATION STREET 2: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vericel Corp CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7349305555 MAIL ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC DATE OF NAME CHANGE: 19960428 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2022-02-11 0000887359 Vericel Corp VCEL 0001778858 Halpin Michael C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE MA 02139 false true false false Chief Operating Officer Common Stock 2022-02-11 4 M false 3500 0 A 10247 D Common Stock 2022-02-11 4 F false 1564 35.26 D 8683 D Restricted Stock Unit 2022-02-11 4 M false 3500 35.26 D Common Stock 3500 7000 D The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 11, 2020. The remaining RSUs will vest in annual installments on February 11, 2023, and February 11, 2024, respectively. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. No expiration date for this type of award. /s/ Sean Flynn, as Attorney-in-Fact for Michael Halpin 2022-02-15